Advertisements


The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»

Category: earningsSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»

Category: blogSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. read more.....»»

Category: blogSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NA.....»»

Category: earningsSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. read more.....»»

Category: blogSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. Conferences Alzheimer's Association In.....»»

Category: earningsSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzingaOct 21st, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks.....»»

Category: blogSource: benzingaOct 21st, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 24th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»

Category: earningsSource: benzingaSep 24th, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, .....»»

Category: earningsSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

Category: blogSource: benzingaSep 16th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results

Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) gained about 1.5 percent. The followi.....»»

Category: earningsSource: benzingaAug 26th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results

Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. read more.....»»

Category: blogSource: benzingaAug 26th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

Here are a few catalysts that can dictate the directional moves of biotech stocks in the upcoming week: read more.....»»

Category: blogSource: benzingaOct 14th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

Here are a few catalysts that can dictate the directional moves of b.....»»

Category: earningsSource: benzingaOct 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»

Category: blogSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»

Category: earningsSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»

Category: earningsSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»

Category: blogSource: benzingaJul 14th, 2018